Aging Brain Structure and Memory in Response to Exercise
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03855475 |
Recruitment Status :
Recruiting
First Posted : February 26, 2019
Last Update Posted : April 21, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mild Cognitive Impairment | Behavioral: Aerobic exercise Behavioral: Stretching | Not Applicable |
Mechanical properties of the human brain, measured with magnetic resonance elastography (MRE), reflect the health of brain tissue. Our previous research has shown that these mechanical properties of the hippocampus are highly sensitive to memory function in young adults. Based on these findings, we believe that these mechanical properties may be strong indicators of memory health in older adults and populations experiencing decline in memory function (i.e. mild cognitive impairment, MCI). Further, our results indicate these properties and associated functions are positively impacted by fitness and exercise training, thus making them potentially ideal markers for brain health in assessing rehabilitation.
The objective of this research is to examine these properties in older adults with and without MCI. We will do the following: (1) determine if there are differences in mechanical properties of memory systems in older adults with and without MCI; (2) establish structure-function relationships between mechanical properties and memory performance in the older adult population; and (3) determine if both mechanical properties and memory performance are impacted by cardiovascular health, both through cross-sectional assessment of aerobic fitness and longitudinal response to exercise training.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 160 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Basic Science |
Official Title: | Mechanical Integrity of Memory Systems in Mild Cognitive Impairment |
Actual Study Start Date : | March 1, 2019 |
Estimated Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | March 31, 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: Aerobic exercise
Exercise training
|
Behavioral: Aerobic exercise
Participants will complete 12 weeks of supervised aerobic exercise, 3 times per week, on a treadmill or stationary bicycle |
Active Comparator: Stretching
Control
|
Behavioral: Stretching
Participants will complete 12 weeks of supervised stretching, 3 times per week |
- Change in brain mechanical properties [ Time Frame: Baseline, 12 weeks ]Investigators are assessing change in brain structure through mechanical properties in response to exercise from baseline to the end of the 12 week program. An MRI scan with magnetic resonance elastography (MRE) will be used to measure properties of brain regions important to memory (e.g. hippocampus).
- Change in relational memory performance [ Time Frame: Baseline, 12 weeks ]Behavioral memory test will be used to assess relational memory through accuracy on a spatial reconstruction task.
- Change in cardiorespiratory fitness [ Time Frame: Baseline, 12 weeks ]Graded exercise test will measure cardiorespiratory fitness through volume of oxygen uptake (VO2)
- Change in brain morphometry [ Time Frame: Baseline, 12 weeks ]MRI will be used to measure brain morphometry, i.e. volume
- Change in brain function [ Time Frame: Baseline, 12 weeks ]MRI will be used to measure brain function, i.e. functional connectivity
- Change in brain white matter integrity [ Time Frame: Baseline, 12 weeks ]Diffusion MRI will be used to measure integrity of white matter tracts
- Change in cognitive function [ Time Frame: Baseline, 12 weeks ]NIH Toolbox will be used to assess cognitive function across several domains

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Cognitive function scores consistent with amnestic mild cognitive impairment based on pre-screening evaluation
- age 60-90 years
- MMSE score >24 at time of initial consent
Exclusion Criteria:
- major psychiatric disorder (e.g. schizophrenia, bipolar disorder, major depression within past two years)
- neurological or autoimmune conditions affecting cognition (e.g. Parkinson's disease, epilepsy, multiple sclerosis, head trauma with loss of consciousness greater than 30 min, large vessel infarct)
- other systemic medical illnesses (e.g. cardiovascular disease, cancer, renal failure, diabetes, chronic obstructive pulmonary disease, liver diseases, hypertension)
- current medication use likely to affect CNS functions (e.g. long active benzodiazepines)
- failed outcome on the baseline graded exercise test
- hypertension (systolic 130+ mmHg OR diastolic 80+ mmHg) from baseline blood pressure measurement
- claustrophobia, metal implants, pacemaker or other factors affecting feasibility and/or safety of MRI scanning
- concussion within last 2 years and more than 3 lifetime concussions
- current smoking (including marijuana) within the past 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03855475
Contact: Curtis L Johnson, PhD | 302-831-4098 | clj@udel.edu |
United States, Delaware | |
University of Delaware | Recruiting |
Newark, Delaware, United States, 19713 | |
Contact: Jane Diehl 302-831-4616 diehlj@udel.edu |
Principal Investigator: | Curtis L Johnson, PhD | University of Delaware |
Responsible Party: | University of Delaware |
ClinicalTrials.gov Identifier: | NCT03855475 |
Other Study ID Numbers: |
1256861 R01AG058853 ( U.S. NIH Grant/Contract ) |
First Posted: | February 26, 2019 Key Record Dates |
Last Update Posted: | April 21, 2023 |
Last Verified: | April 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Exercise Memory Brain |
Cognitive Dysfunction Cognition Disorders Neurocognitive Disorders Mental Disorders |